Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M445Revenue $M13.5Net Margin (%)-453.4Z-Score11.9
Enterprise Value $M345EPS $-1.4Operating Margin %-374.6F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-453.8Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %-17.1Quick Ratio11.7Cash flow > EarningsY
Price/Sales45.95-y EBITDA Growth Rate %-15.1Current Ratio11.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-36.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-45.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.6ROI % (ttm)-83.0Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOJean-Marie Eveillard 2014-03-31 Sold Out $9.76 - $15.28
($11.92)
$ 7.35-38%Sold Out0
INOJean-Marie Eveillard 2013-12-31 Buy $6.92 - $11.88
($8.28)
$ 7.35-11%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIES PETERCFO 2014-10-09Buy3,960$10.1-30.2view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-29.57view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-27.62view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.7-18.97view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.06-22.19view
Kim Jong JosephCEO 2014-04-15Buy6,250$9-21.67view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.28-3.16view
Bagarazzi MarkChief Medical Officer 2013-04-16Buy15,000$2.24214.73view
Kim Jong JosephCEO, 10% Owner 2013-04-02Buy22,500$2252.5view
Cabrera AngelDirector 2013-03-22Buy10,000$2.16226.39view

Press Releases about INO :

    Quarterly/Annual Reports about INO:

    News about INO:

    Articles On GuruFocus.com
    Inovio Pharmaceuticals' CEO Dr. J. Joseph Kim Interviewed by The Life Sciences Report Oct 30 2014 
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
    comment on INO May 10 2013 
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    Any opinions regarding Apr 12 2010 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Mar 03 2015
    MedImmune, NIST announce five-year partnership for biological drug research Feb 20 2015
    Video-Revolutionizing the Fight Against Cancers and Infectious Diseases for Inovio Pharmaceuticals,... Feb 09 2015
    U.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum Feb 03 2015
    Inovio Pharmaceuticals to Present at Upcoming Investor Conferences Feb 02 2015
    Inovio Pharmaceuticals to Present at Upcoming Investor Conferences Feb 02 2015
    Investment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum Jan 29 2015
    Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia... Jan 29 2015
    Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia... Jan 29 2015
    Document for Inovio Pharmaceuticals, Inc. Jan 13 2015
    Video-Corporate Presentation - January 2015 for Inovio Pharmaceuticals, Inc. Jan 12 2015
    Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference Jan 07 2015
    Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference Jan 07 2015
    Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV Jan 06 2015
    Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV Jan 06 2015
    Inovio begins human testing of cancer therapy Dec 19 2014
    Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers Dec 18 2014
    Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers Dec 18 2014
    Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology Dec 17 2014
    Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology Dec 17 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK